| # | Drug | Count |
|---|---|---|
| 0 | BACILLUS CALMETTE-GUERIN | 187 |
| 1 | PIOGLITAZONE | 147 |
| 2 | METFORMIN | 89 |
| 3 | METFORMIN ER 500 MG | 83 |
| 4 | METFORMIN ER 750 MG | 83 |
| 5 | SITAGLIPTIN | 40 |
| 6 | GEMCITABINE HYDROCHLORIDE | 36 |
| 7 | ASPIRIN | 34 |
| 8 | ASPIRIN 325 MG | 33 |
| 9 | ASPIRIN 81 MG | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BACILLUS CALMETTE-GUERIN | 187 | 0.1050 |
| 1 | NOGAPENDEKIN ALFA INBAKICEPT-PMLN | 2 | 0.0408 |
| 2 | NADOFARAGENE FIRADENOVEC-VNCG | 13 | 0.0249 |
| 3 | VALRUBICIN | 3 | 0.0169 |
| 4 | ALITRETINOIN | 1 | 0.0084 |
| 5 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 10 | 0.0079 |
| 6 | PIOGLITAZONE | 147 | 0.0034 |
| 7 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 8 | DAPRODUSTAT | 3 | 0.0015 |
| 9 | ENFORTUMAB VEDOTIN | 9 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 187 | 0.1050 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 3 | 0.0013 |
| 2 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 3 | Sulfonylurea [EPC] | 41 | 0.0003 |
| 4 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 6 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 7 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 8 | beta3-Adrenergic Agonist [EPC] | 10 | 0.0002 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 17 | 0.0002 |